Home / Inspections / 1153219

FDA Inspection 1153219 — Octapharma Plasma Inc

Octapharma Plasma Inc — FEI 3006604254

The FDA completed an inspection of Octapharma Plasma Inc on September 14, 2021 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 14, 2021
Fiscal Year
2021
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Omaha, NE (United States)

Facility

Other inspections at this facility

  • 1009884 (NAI Fri Mar 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 909240 (VAI Thu Jan 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 820739 (NAI Wed Feb 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 732180 (VAI Tue Jun 07 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 608945 (NAI Fri Aug 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources